{"id":70919,"date":"2024-04-09T12:24:49","date_gmt":"2024-04-09T12:24:49","guid":{"rendered":"https:\/\/www.imperialcrs.com\/blog\/?p=70919"},"modified":"2024-04-09T12:24:49","modified_gmt":"2024-04-09T12:24:49","slug":"clinical-trial-binders-are-you-doing-it-the-hard-way","status":"publish","type":"post","link":"https:\/\/www.imperialcrs.com\/blog\/study-site-management\/clinical-trial-binders-are-you-doing-it-the-hard-way\/","title":{"rendered":"Clinical Trial Binders: Are You Doing it the Hard Way?"},"content":{"rendered":"<p>Clinical trials have become more and more complex over the last decade, largely due to the challenges driven by an increasingly global reach. As a sponsor, are you making it hard for clinical trial teams? Learn about a unique solution to managing clinical trial binders.<\/p>\n<h2>A Challenging Part of Study Startup \u2013 Clinical Trial Binders<\/h2>\n<p>Since 2016, the highest number of clinical research registrations on <a href=\"https:\/\/clinicaltrials.gov\/\">clinicaltrials.gov<\/a> include clinical studies with sites in the Western Pacific, Europe, and Latin America. This spread of global clinical trial activation continues as recruitment efforts increase in lower-income regions and those with unmet medical needs. Clearly, the complexity phenomenon isn\u2019t going away. It\u2019s a challenge that study teams face, especially as they undertake the critical steps of study startup.<\/p>\n<p>Investigator Site File (ISF) and Pharmacy binders are a requirement for all clinical trials in the <a href=\"https:\/\/www.imperialcrs.com\/blog\/imperial-graphics\/planning-printed-clinical-trial-materials-for-investigator-meetings-and-study-startup\/\">study startup<\/a> process, and clinical trial sites are faced with meeting each country and region\u2019s regulatory requirements regarding what to include. These binders contain key study information, including:<\/p>\n<ul>\n<li>Protocol requirements<\/li>\n<li>Inclusion and exclusion criteria<\/li>\n<li>Regulatory requirements that impact the clinical trial<\/li>\n<\/ul>\n<h2>Binder Burden<\/h2>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignleft size-medium wp-image-70922\" src=\"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2024\/04\/Investigator-Site-File-And-Pharmacy-Binders-300x200.jpg\" alt=\"\" width=\"300\" height=\"200\" srcset=\"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2024\/04\/Investigator-Site-File-And-Pharmacy-Binders-300x200.jpg 300w, https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2024\/04\/Investigator-Site-File-And-Pharmacy-Binders-768x512.jpg 768w, https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2024\/04\/Investigator-Site-File-And-Pharmacy-Binders-585x390.jpg 585w, https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2024\/04\/Investigator-Site-File-And-Pharmacy-Binders-263x175.jpg 263w, https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2024\/04\/Investigator-Site-File-And-Pharmacy-Binders.jpg 800w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<p>Step one is the creation of a master set of clinical trial documents. From there, documents for study startup are adapted to each site, country, and region based on regulatory and governmental needs. Thirty percent of studies are U.S. only, and 54 percent are based outside of the U.S. With 66 percent of studies recruiting globally outside of the U.S., these documents must be revised frequently. The burden this places on study teams can be enormous.<\/p>\n<p>And it\u2019s often a race. Finalizing the study materials and adapting them to include site-specific documentation is often very last minute, with only a week or two available to make final ICF and Pharmacy clinical trial binder files ready to include within the binders. This burden typically falls on local site teams and clinical trial managers to finalize and generate these documents at a site level.<\/p>\n<p>Research sites&#8217; startup fees may not be enough to cover their time, and clinical trial managers may not bill correctly for the steps, time, and work involved. This is not cost or time-effective. It creates animosity between site teams, wider project support teams, and sponsors, and most importantly, it doesn\u2019t provide the full accounting and audit of each step involved in the study startup. We found that local teams spend an average of 6-7 hours customizing clinical trial binders per study country. This has been the norm for a very long time.<\/p>\n<h2>Clinical Trial Binders: An Imperial Solution<\/h2>\n<p>One of our clients approached us to discuss these challenges and see if we could find a solution to enable a smooth provision of study startup materials for global site locations. This was a challenge, of course. The development, printing, and shipping of the materials would need to be:<\/p>\n<ul>\n<li>Centrally managed<\/li>\n<li>On demand<\/li>\n<li>Flexible<\/li>\n<li>Adaptable<\/li>\n<li>Immediate<\/li>\n<\/ul>\n<p>Our business development, operations, project management, prepress, and production teams worked together. Using our proprietary digital platform, we created a unique solution for site-specific clinical trial binder development and printing. This exciting process does several things:<\/p>\n<ul>\n<li>Provides sponsors, CROs, and their study teams with greater control of their binder projects, supported by our dedicated project management team.<\/li>\n<li>Removes the need for multiple localized solutions that require contracts, vetting, auditing, and managing.<\/li>\n<li>Allows CROs to focus local country resources on other important elements of study startup, as well as monetize previously unbilled time for the development of the customized binders.<\/li>\n<li>Gives our clients all over the globe the quick, flexible, dynamic solution that they need.<\/li>\n<li>Improves the satisfaction of clinical trial sites.<\/li>\n<\/ul>\n<p>In addition, our clients benefit from free warehousing, a 24\/7 portal for file uploads, digital proofs, inventory management, and shipment tracking. That\u2019s just a few of the many reasons our clients have adopted and implemented this solution.<\/p>\n<h2>The Imperial Advantage<\/h2>\n<p><img loading=\"lazy\" decoding=\"async\" class=\" wp-image-70923 alignright\" src=\"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2024\/04\/Imperial-Solves-Problems-e1712616399617.jpg\" alt=\"\" width=\"362\" height=\"234\" srcset=\"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2024\/04\/Imperial-Solves-Problems-e1712616399617.jpg 694w, https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2024\/04\/Imperial-Solves-Problems-e1712616399617-300x194.jpg 300w, https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2024\/04\/Imperial-Solves-Problems-e1712616399617-585x378.jpg 585w\" sizes=\"auto, (max-width: 362px) 100vw, 362px\" \/>The burden on project teams and local site teams increases exponentially with the <a href=\"https:\/\/www.imperialcrs.com\/blog\/imperial-graphics\/mastering-4-global-clinical-trial-logistics-challenges\/\">growing global footprint<\/a> of clinical trials. It\u2019s part of Imperial\u2019s core goals to do the right thing for our clients. By creating this solution to meet the needs of our clients and, in turn, reducing costs and time, we hope we are exceeding their expectations. And exceeding expectations is one of our corporate goals.<\/p>\n<p>We are in the solutions business. <a href=\"https:\/\/www.imperialcrs.com\/contact\/\">Let us know<\/a> your pain points, and Imperial will work with you on a solution.<\/p>\n<p>_________<br \/>\nSources:<br \/>\n<a href=\"https:\/\/www.who.int\/observatories\/global-observatory-on-health-research-and-development\/monitoring\/number-of-clinical-trials-by-year-country-who-region-and-income-group\">World Health Organization data<\/a> on trials by year, country, region, and income group<br \/>\n<a href=\"https:\/\/classic.clinicaltrials.gov\/ct2\/resources\/trends\">ClinicalTrials.gov information<\/a>: trends, charts, and maps<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Clinical trials have become more and more complex over the last decade, largely due to the challenges driven by an increasingly global reach. As a sponsor, are you making it hard for clinical trial teams? Learn about a unique solution to managing clinical trial binders.&hellip;<\/p>\n","protected":false},"author":16,"featured_media":70924,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[22,47],"tags":[83,1769,2043,465,693,648,464,698,50,101,2006,1334,563,676,680],"class_list":["post-70919","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business-insights","category-study-site-management","tag-clinical-research","tag-clinical-research-management","tag-clinical-research-organizations","tag-clinical-research-strategies","tag-clinical-study-startup","tag-clinical-trial-innovation","tag-clinical-trial-management","tag-clinical-trial-startup-challenges","tag-clinical-trials","tag-cro","tag-cros","tag-global-clinical-research","tag-global-clinical-trial-challenges","tag-investigator-binder","tag-research-study-startup"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Clinical Trial Binders: Are You Doing it the Hard Way? - Imperial Clinical Research Services Blog<\/title>\n<meta name=\"description\" content=\"Learn about a unique solution to managing clinical trial binders in this time of increasingly complex and global clinical trials.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.imperialcrs.com\/blog\/study-site-management\/clinical-trial-binders-are-you-doing-it-the-hard-way\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Clinical Trial Binders: Are You Doing it the Hard Way? - Imperial Clinical Research Services Blog\" \/>\n<meta property=\"og:description\" content=\"Learn about a unique solution to managing clinical trial binders in this time of increasingly complex and global clinical trials.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.imperialcrs.com\/blog\/study-site-management\/clinical-trial-binders-are-you-doing-it-the-hard-way\/\" \/>\n<meta property=\"og:site_name\" content=\"Imperial Clinical Research Services Blog\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-09T12:24:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2024\/04\/Clinical-Trial-Binders.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"942\" \/>\n\t<meta property=\"og:image:height\" content=\"638\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Imogen Cheese\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Imogen Cheese\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/study-site-management\\\/clinical-trial-binders-are-you-doing-it-the-hard-way\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/study-site-management\\\/clinical-trial-binders-are-you-doing-it-the-hard-way\\\/\"},\"author\":{\"name\":\"Imogen Cheese\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/#\\\/schema\\\/person\\\/60b35e1f853f93f54238e945cad4e6ba\"},\"headline\":\"Clinical Trial Binders: Are You Doing it the Hard Way?\",\"datePublished\":\"2024-04-09T12:24:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/study-site-management\\\/clinical-trial-binders-are-you-doing-it-the-hard-way\\\/\"},\"wordCount\":767,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/study-site-management\\\/clinical-trial-binders-are-you-doing-it-the-hard-way\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/Clinical-Trial-Binders.jpg\",\"keywords\":[\"Clinical Research\",\"Clinical Research Management\",\"clinical research organizations\",\"Clinical Research Strategies\",\"Clinical Study Startup\",\"Clinical Trial Innovation\",\"Clinical Trial Management\",\"Clinical Trial Startup Challenges\",\"Clinical Trials\",\"CRO\",\"CROs\",\"Global Clinical Research\",\"Global Clinical Trial Challenges\",\"Investigator Binder\",\"Research Study Startup\"],\"articleSection\":[\"Business Insights\",\"Study Site Management\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/study-site-management\\\/clinical-trial-binders-are-you-doing-it-the-hard-way\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/study-site-management\\\/clinical-trial-binders-are-you-doing-it-the-hard-way\\\/\",\"url\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/study-site-management\\\/clinical-trial-binders-are-you-doing-it-the-hard-way\\\/\",\"name\":\"Clinical Trial Binders: Are You Doing it the Hard Way? - Imperial Clinical Research Services Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/study-site-management\\\/clinical-trial-binders-are-you-doing-it-the-hard-way\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/study-site-management\\\/clinical-trial-binders-are-you-doing-it-the-hard-way\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/Clinical-Trial-Binders.jpg\",\"datePublished\":\"2024-04-09T12:24:49+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/#\\\/schema\\\/person\\\/60b35e1f853f93f54238e945cad4e6ba\"},\"description\":\"Learn about a unique solution to managing clinical trial binders in this time of increasingly complex and global clinical trials.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/study-site-management\\\/clinical-trial-binders-are-you-doing-it-the-hard-way\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/study-site-management\\\/clinical-trial-binders-are-you-doing-it-the-hard-way\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/study-site-management\\\/clinical-trial-binders-are-you-doing-it-the-hard-way\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/Clinical-Trial-Binders.jpg\",\"contentUrl\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/Clinical-Trial-Binders.jpg\",\"width\":942,\"height\":638},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/study-site-management\\\/clinical-trial-binders-are-you-doing-it-the-hard-way\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Clinical Trial Binders: Are You Doing it the Hard Way?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/\",\"name\":\"Imperial Clinical Research Services Blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/#\\\/schema\\\/person\\\/60b35e1f853f93f54238e945cad4e6ba\",\"name\":\"Imogen Cheese\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89204e73b02151fda5c218f68d87117d5ca6ba0859246f48014aefa6a0cfe490?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89204e73b02151fda5c218f68d87117d5ca6ba0859246f48014aefa6a0cfe490?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89204e73b02151fda5c218f68d87117d5ca6ba0859246f48014aefa6a0cfe490?s=96&d=mm&r=g\",\"caption\":\"Imogen Cheese\"},\"description\":\"Imogen is Imperial\u2019s director of business development for the U.K. and Europe. She has 20 years of business management experience with a deep understanding of trial setup and recruitment in the clinical sector. She is the founder and director of Melanoma Patient Conference CIC, a non-profit education and support group that holds an annual conference for 300 melanoma patients. Imogen is an energetic advocate for the patient community, frequently speaking internationally at events, and providing guidance for ongoing initiatives impacting patients. She believes an informed patient is the best partner for long-term success in clinical trials.\",\"url\":\"https:\\\/\\\/www.imperialcrs.com\\\/blog\\\/author\\\/icheese\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Clinical Trial Binders: Are You Doing it the Hard Way? - Imperial Clinical Research Services Blog","description":"Learn about a unique solution to managing clinical trial binders in this time of increasingly complex and global clinical trials.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.imperialcrs.com\/blog\/study-site-management\/clinical-trial-binders-are-you-doing-it-the-hard-way\/","og_locale":"en_US","og_type":"article","og_title":"Clinical Trial Binders: Are You Doing it the Hard Way? - Imperial Clinical Research Services Blog","og_description":"Learn about a unique solution to managing clinical trial binders in this time of increasingly complex and global clinical trials.","og_url":"https:\/\/www.imperialcrs.com\/blog\/study-site-management\/clinical-trial-binders-are-you-doing-it-the-hard-way\/","og_site_name":"Imperial Clinical Research Services Blog","article_published_time":"2024-04-09T12:24:49+00:00","og_image":[{"width":942,"height":638,"url":"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2024\/04\/Clinical-Trial-Binders.jpg","type":"image\/jpeg"}],"author":"Imogen Cheese","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Imogen Cheese","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.imperialcrs.com\/blog\/study-site-management\/clinical-trial-binders-are-you-doing-it-the-hard-way\/#article","isPartOf":{"@id":"https:\/\/www.imperialcrs.com\/blog\/study-site-management\/clinical-trial-binders-are-you-doing-it-the-hard-way\/"},"author":{"name":"Imogen Cheese","@id":"https:\/\/www.imperialcrs.com\/blog\/#\/schema\/person\/60b35e1f853f93f54238e945cad4e6ba"},"headline":"Clinical Trial Binders: Are You Doing it the Hard Way?","datePublished":"2024-04-09T12:24:49+00:00","mainEntityOfPage":{"@id":"https:\/\/www.imperialcrs.com\/blog\/study-site-management\/clinical-trial-binders-are-you-doing-it-the-hard-way\/"},"wordCount":767,"commentCount":0,"image":{"@id":"https:\/\/www.imperialcrs.com\/blog\/study-site-management\/clinical-trial-binders-are-you-doing-it-the-hard-way\/#primaryimage"},"thumbnailUrl":"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2024\/04\/Clinical-Trial-Binders.jpg","keywords":["Clinical Research","Clinical Research Management","clinical research organizations","Clinical Research Strategies","Clinical Study Startup","Clinical Trial Innovation","Clinical Trial Management","Clinical Trial Startup Challenges","Clinical Trials","CRO","CROs","Global Clinical Research","Global Clinical Trial Challenges","Investigator Binder","Research Study Startup"],"articleSection":["Business Insights","Study Site Management"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.imperialcrs.com\/blog\/study-site-management\/clinical-trial-binders-are-you-doing-it-the-hard-way\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.imperialcrs.com\/blog\/study-site-management\/clinical-trial-binders-are-you-doing-it-the-hard-way\/","url":"https:\/\/www.imperialcrs.com\/blog\/study-site-management\/clinical-trial-binders-are-you-doing-it-the-hard-way\/","name":"Clinical Trial Binders: Are You Doing it the Hard Way? - Imperial Clinical Research Services Blog","isPartOf":{"@id":"https:\/\/www.imperialcrs.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.imperialcrs.com\/blog\/study-site-management\/clinical-trial-binders-are-you-doing-it-the-hard-way\/#primaryimage"},"image":{"@id":"https:\/\/www.imperialcrs.com\/blog\/study-site-management\/clinical-trial-binders-are-you-doing-it-the-hard-way\/#primaryimage"},"thumbnailUrl":"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2024\/04\/Clinical-Trial-Binders.jpg","datePublished":"2024-04-09T12:24:49+00:00","author":{"@id":"https:\/\/www.imperialcrs.com\/blog\/#\/schema\/person\/60b35e1f853f93f54238e945cad4e6ba"},"description":"Learn about a unique solution to managing clinical trial binders in this time of increasingly complex and global clinical trials.","breadcrumb":{"@id":"https:\/\/www.imperialcrs.com\/blog\/study-site-management\/clinical-trial-binders-are-you-doing-it-the-hard-way\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.imperialcrs.com\/blog\/study-site-management\/clinical-trial-binders-are-you-doing-it-the-hard-way\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.imperialcrs.com\/blog\/study-site-management\/clinical-trial-binders-are-you-doing-it-the-hard-way\/#primaryimage","url":"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2024\/04\/Clinical-Trial-Binders.jpg","contentUrl":"https:\/\/www.imperialcrs.com\/blog\/wp-content\/uploads\/2024\/04\/Clinical-Trial-Binders.jpg","width":942,"height":638},{"@type":"BreadcrumbList","@id":"https:\/\/www.imperialcrs.com\/blog\/study-site-management\/clinical-trial-binders-are-you-doing-it-the-hard-way\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.imperialcrs.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Clinical Trial Binders: Are You Doing it the Hard Way?"}]},{"@type":"WebSite","@id":"https:\/\/www.imperialcrs.com\/blog\/#website","url":"https:\/\/www.imperialcrs.com\/blog\/","name":"Imperial Clinical Research Services Blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.imperialcrs.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.imperialcrs.com\/blog\/#\/schema\/person\/60b35e1f853f93f54238e945cad4e6ba","name":"Imogen Cheese","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89204e73b02151fda5c218f68d87117d5ca6ba0859246f48014aefa6a0cfe490?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89204e73b02151fda5c218f68d87117d5ca6ba0859246f48014aefa6a0cfe490?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89204e73b02151fda5c218f68d87117d5ca6ba0859246f48014aefa6a0cfe490?s=96&d=mm&r=g","caption":"Imogen Cheese"},"description":"Imogen is Imperial\u2019s director of business development for the U.K. and Europe. She has 20 years of business management experience with a deep understanding of trial setup and recruitment in the clinical sector. She is the founder and director of Melanoma Patient Conference CIC, a non-profit education and support group that holds an annual conference for 300 melanoma patients. Imogen is an energetic advocate for the patient community, frequently speaking internationally at events, and providing guidance for ongoing initiatives impacting patients. She believes an informed patient is the best partner for long-term success in clinical trials.","url":"https:\/\/www.imperialcrs.com\/blog\/author\/icheese\/"}]}},"_links":{"self":[{"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/posts\/70919","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/comments?post=70919"}],"version-history":[{"count":6,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/posts\/70919\/revisions"}],"predecessor-version":[{"id":70931,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/posts\/70919\/revisions\/70931"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/media\/70924"}],"wp:attachment":[{"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/media?parent=70919"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/categories?post=70919"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.imperialcrs.com\/blog\/wp-json\/wp\/v2\/tags?post=70919"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}